TITLE

Cancer Stem Cell Camps

AUTHOR(S)
Fox, Cynthia
PUB. DATE
March 2014
SOURCE
Bioscience Technology;2014, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article presents a research study on two camps formed in the breast cancer stem cell. Topics discussed include the possibility of the growth of cancers from stem cells, cancer stem cell, and the hierarchy in normal cells. Also discussed is the presence of rare, immature, and organ and tissue-specific stem cells in all organs.
ACCESSION #
95653404

 

Related Articles

  • Proceedings of the National Academy of Sciences: New findings in breast cancer.  // Biomedical Market Newsletter;4/21/2012, Vol. 21, p1 

    The article focuses on a research which found that luminal-likebreast cancer cells with no detectable stem cell qualities can generate larger tumors than their basal-like counterparts, a finding which could impact future breast cancer diagnosis and treatment.

  • GROWTH INDUSTRY. Jonietz, Erika // Technology Review;Jan/Feb2002, Vol. 105 Issue 1, p24 

    Focuses on the issues relating to adult stem cells. Production of cells in repairing damaged organs and tissues; Use of living cells in patients with liver failure; Difficulty associated with mass-production of stem cells.

  • Broccoli Compound Targets Breast Cancer Stem Cells. Dye, Dayna // Life Extension;Aug2010, Vol. 16 Issue 8, p14 

    The article discusses research which was conducted at the University of Michigan and found that a chemical compound called sulforaphane, which is found in broccoli and broccoli sprouts, targets breast cancer stem cells in cell cultures and in mice.

  • EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells. Zhaomei Mu; Hua Li; Fernandez, Sandra V.; Alpaugh, Katherine R.`; Rugang Zhang; Cristofanilli, Massimo // Journal of Experimental & Clinical Cancer Research (17569966);2013, Vol. 32 Issue 1, p1 

    Introduction: Inflammatory breast cancer (IBC) is the most metastatic variant of breast cancer with the poorest survival in all types of breast cancer patients and presently therapeutic targets for IBC are very limited. Enhancer of zeste homolog 2 (EZH2) is frequently expressed in human IBC and...

  • Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth/Effects of estrogen on the proportion of stem cells in the breast.  // Current Medical Literature: Breast Cancer;2011, Vol. 23 Issue 4, p131 

    The article discusses the results of studies that examined the expression of estrogen receptor (ER)-alpha in breast carcinoma. It references two studies published in the "Breast Cancer Research and Treatment" journal. The first study investigated the effect of ER-alpha overexpression in the...

  • Hold the Champagne. Healy, Bernadine // U.S. News & World Report;6/13/2005, Vol. 138 Issue 22, p71 

    Focuses on progress in breast cancer research and treatment. Evidence in the progress that publicly funded medical research works; Threat posed to women by metastatic breast cancer, and need to block cancer's ability to spread wildly; Evidence suggesting that stem cells gone bad may be the root...

  • Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes. Schmitt, Fernando; Ricardo, Sara; Vieira, André; Dionísio, Maria; Paredes, Joana // Virchows Archiv;Jun2012, Vol. 460 Issue 6, p545 

    The identification and characterization of cancer stem cells might lead to more effective control of neoplastic disease, by directing therapies to the most aggressive cells. For that reason, the identification of cancer stem cells (CSCs) in breast tumours is one of the priorities in breast...

  • Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types. de Beça, Francisco Ferro; Caetano, Pedro; Gerhard, Renê; Alvarenga, Cesar Augusto; Gomes, Madalena; Paredes, Joana; Schmitt, Fernando // Journal of Clinical Pathology;Mar2013, Vol. 66 Issue 3, p187 

    Aims CD44, CD24 and ALDH1 are the most consistently used biomarkers to identify and characterise the breast cancer stem cell (CSC) phenotype. However, most studies performed until now analysed samples of invasive ductal carcinomas of no special type (IDC-NST). Therefore, prevalence and clinical...

  • Pluripotent Stem cell mirNAs and Metastasis in invasive Breast cancer. Volinia, Stefano; Nuovo, Gerard; Drusco, Alessandra; Costinean, Stefan; Abujarour, Ramzey; Desponts, Caroline; Garofalo, Michela; Baffa, Raffaele; Aeqilan, Rami; Maharry, Kati; Sana Ramiro, Maria Elena; Garzon; Di Leva, Gianpiero; Gasparini, Pierluigi; Dama, Paola; Marchesini, Jlenia; Galasso, Marco; Manfrini, Marco; Zerbinati, Carlotta; Corrà, Fabio // JNCI: Journal of the National Cancer Institute;12/10/2014, Vol. 106 Issue 12, p1 

    Background The purpose of this study is to determine whether microRNA for pluripotent stem cells are also expressed in breast cancer and are associated with metastasis and outcome. Methods We studied global microRNA profiles during differentiation of human embryonic stem cells (n =26) and in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics